|
J Biol Chem, Vol. 273, Issue 26, 16409-16414, June 26, 1998
Protein Kinase C Mediates Ethanol-induced Up-regulation of
L-type Calcium Channels*
Edward H.
Gerstin Jr. §,
Thomas
McMahon §,
Jahan
Dadgar , and
Robert O.
Messing ¶
From the Department of Neurology, Ernest Gallo Clinic
and Research Center and the ¶ Graduate Programs in Neuroscience
and Biomedical Sciences, University of California,
San Francisco, California 94110
 |
ABSTRACT |
Brief ethanol exposure inhibits L-type,
voltage-gated calcium channels in neural cells, whereas chronic
exposure increases the number of functional channels. In PC12 cells,
this adaptive response is mediated by protein kinase C (PKC), but the
PKC isozyme responsible is unknown. Since chronic ethanol exposure
increases expression of PKC and PKC , we investigated the role
these isozymes play in up-regulation of L-type channels by ethanol.
Incubation with the PKC inhibitor GF 109203X or expression of a PKC
fragment that inhibits phorbol ester-induced PKC translocation
largely prevented ethanol-induced increases in dihydropyridine binding and K+-stimulated 45Ca2+
uptake. A corresponding PKC fragment had no effect on this response. These findings indicate that PKC mediates up-regulation of L-type channels by ethanol. Remaining responses to ethanol in cells expressing the PKC fragment were not inhibited by GF 109203X, indicating that
PKC -independent mechanisms also contribute. PKC overexpression increased binding sites for dihydropyridine and L-channel antagonists, but did not increase K+-stimulated
45Ca2+ uptake, possibly because of homeostatic
responses that maintain base-line levels of channel function. Since
L-type channels modulate drinking behavior and contribute to neuronal
hyperexcitability during alcohol withdrawal, these findings suggest an
important role for PKC in alcohol consumption and dependence.
 |
INTRODUCTION |
Understanding biochemical mechanisms that underlie alcohol
tolerance and dependence may lead to new treatments for alcoholism. In
nonalcoholic persons, intoxication develops at blood alcohol levels of
10-35 mM, and acute tolerance develops rapidly, so that after a few hours, an individual can appear sober at alcohol levels that previously caused intoxication (1). The mechanism for acute
tolerance may involve activation of Fyn kinase and reduced sensitivity
of tyrosine-phosphorylated N-methyl-D-aspartate
receptors to inhibition by alcohol (2). Chronic tolerance is
characteristic of alcoholism, and its magnitude in alcoholics can be
quite striking. For example, blood alcohol concentrations above 100 mM produce coma in a nonalcoholic person, whereas human
alcoholics may appear sober or only mildly intoxicated with blood
levels of 100-150 mM (3, 4).
The ability of ethanol to alter the function of neuronal
voltage-dependent calcium channels appears to contribute to
chronic tolerance. In several neural preparations, ethanol
inhibits voltage-dependent calcium influx and calcium
currents (5-13). Chronic exposure results in the development of
tolerance to the inhibitory actions of ethanol on calcium channels (6,
7). The mechanisms underlying this adaptive response have been studied
most in the neural cell line PC12. In PC12 cells, prolonged exposure to
25-200 mM ethanol for 2-6 days produces a reversible
concentration- and time-dependent increase in
K+-evoked 45Ca2+ uptake (8, 9, 14)
and L-type calcium currents (14) measured in the absence of ethanol.
This is associated with a corresponding increase in the number of
binding sites for dihydropyridine Ca2+ channel antagonists
(8, 9), suggesting that cells adapt to chronic ethanol exposure by
increasing expression of functional L-type calcium channels. Similar
increases in dihydropyridine binding have been detected in
ethanol-treated NG108-15 neuroblastoma × glioma cells (15) and in
brain membranes from ethanol-treated rats (16).
Up-regulation of L-type channels could promote alcohol consumption
since L-channel antagonists reduce consumption in animals (17-20).
Increases in L-type calcium channels may also contribute to the intense
neuronal hyperexcitability observed during alcohol withdrawal (21). A
role for L-type channels in alcohol withdrawal syndromes is supported
by evidence that L-channel antagonists reduce tremors, seizures, and
mortality in alcohol-dependent rodents deprived of ethanol
(22-24). Moreover, ethanol-induced increases in binding sites for
L-channel antagonists are greater in mice bred for severe alcohol
withdrawal seizures than in mice bred for minor signs of alcohol
withdrawal (25). These findings suggest that L-channel
up-regulation plays an important role in alcohol dependence.
Protein kinase C (PKC)1 is a
family of phospholipid-dependent serine/threonine kinases
involved in cell growth and differentiation, neurotransmitter release
and receptor regulation, ion channel modulation, and gene expression
(26). Eleven PKC isozymes have been identified ( , I, II, ,
, , , , , , and µ), and they differ in structure
and requirements for activation by diacylglycerol and calcium (26-28).
In PC12 cells, we found that up-regulation of L-type channels by
ethanol is inhibited by the kinase inhibitors sphingosine and polymyxin
B (29). The effect of sphingosine is reversed by phorbol esters that
activate all PKC isozymes except PKC and PKC (26), suggesting
that ethanol-induced up-regulation of L-type channels requires
activation of a phorbol ester-sensitive PKC. We also found that chronic
ethanol exposure increases total PKC activity, high affinity phorbol
ester binding, and PKC-mediated phosphorylation in PC12 cells (30).
This is associated with a selective increase in immunoreactivity (30)
and mRNA (31) for two PKC isozymes, PKC and PKC . Taken
together, these findings suggest that chronic exposure to ethanol
up-regulates functional L-type channels through a mechanism that
involves ethanol-induced increases in expression of PKC or
PKC .
In this paper, we examined whether PKC or PKC mediates
ethanol-induced increases in L-type channels by using stably
transfected PC12 cell lines that express the V1 or V1 fragment,
which are derived from the first variable domains of PKC and PKC ,
respectively. These fragments selectively inhibit phorbol ester-induced
translocation of the corresponding isozyme, and the V1 fragment
specifically prevents phorbol ester-mediated inhibition of contraction
in cultured cardiac myocytes (32) and enhancement of nerve growth
factor-induced neurite outgrowth and mitogen-activated protein kinase
activation by ethanol or phorbol esters in PC12 cells (33). We found
that chronic exposure to ethanol increased K+-stimulated
45Ca2+ uptake and dihydropyridine binding in
PC12 cells, vector-transfected cells, and cells expressing V1, but
not in cells expressing V1. We also found that overexpression of
PKC increased dihydropyridine binding, but did not enhance
K+-stimulated 45Ca2+ uptake. These
results demonstrate that PKC mediates increases in
L-type calcium channels induced by chronic exposure to
ethanol. These results are the first to demonstrate a functional role
for PKC in neural cells.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
In these experiments, we used PC12 cells
obtained from Dr. John A. Wagner (Cornell University, New York). Cells
were grown at 37 °C in plastic tissue culture flasks in Dulbecco's
modified Eagle's medium supplemented with 5% fetal calf serum, 10%
horse serum, 50 units/ml penicillin, 50 µg/ml streptomycin, and 2 mM glutamine in a humidified atmosphere of 90% air and
10% CO2. Cells were cultured with ethanol in tightly
capped tissue culture flasks or in six-well plates wrapped in Parafilm,
and the medium was changed daily as described previously (8, 29).
Parallel control samples were cultured in a similar manner without
ethanol. Stably transfected cell lines that overexpress PKC or
PKC have been described previously (34). Cell lines that express
Flag epitope-tagged V1 or V1 were created and analyzed by reverse
transcriptase-polymerase chain reaction and Western analysis for the
Flag epitope tag as described (33).
Phorbol Ester-stimulated Translocation of PKC --
Cells
(4 × 106) were plated on 100-mm2 plastic
tissue culture plates. After 2 days, the plates were rinsed with 10 ml
of Dulbecco's modified Eagle's medium and incubated with or without
30 nM phorbol 12-myristate 13-acetate (PMA) for 2 min at
37 °C. Cells were rinsed twice with Ca2+- and
Mg2+-free phosphate-buffered saline and scraped into
ice-cold buffer containing 20 mM Tris-HCl, pH 7.5, 2 mM EDTA, 10 mM EGTA, 40 µg/ml leupeptin, 40 µg/ml aprotinin, 20 µg/ml soybean trypsin inhibitor, and 1 mM phenylmethylsulfonyl fluoride. Cells were homogenized in
a Teflon-glass homogenizer, and sucrose was added to a final concentration of 250 mM. Samples were then centrifuged at
150,000 × g for 1 h, and the supernatant was
saved as the cytosolic fraction. The pellet was dispersed by
sonication, and samples of supernatant and pellet derived from 100 µg
of crude homogenate were analyzed by Western analysis as described
(33).
K+-stimulated 45Ca2+
Uptake--
PC12 cells were plated onto
poly-D-lysine-coated six-well tissue culture plates at a
density of 0.8-1.6 × 106 cells/well. After 24 h, cells were cultured for another 1-6 days in the presence or absence
of ethanol. On the day of assay, cells were rinsed twice with 1 ml of 5 mM KCl buffer (85 mM NaCl, 5 mM
KCl, 45 mM choline chloride, 2 mM
CaCl2, 5 mM glucose, and 25 mM
HEPES, pH 7.4) at room temperature, and incubated in the same buffer
for 25 min. Cells were then incubated at 25 °C in 5 or 50 mM KCl buffer containing 0.75 µCi of
45Ca2+. The composition of the 50 mM KCl buffer was identical to that of the 5 mM
KCl buffer except that choline chloride was replaced by KCl. After
incubation for 2.5 min, cells were washed four times with 2.5 ml of
ice-cold 5 mM KCl buffer and incubated overnight with 1 ml
of 1 M NaOH. Radioactivity in neutralized samples was measured by liquid scintillation counting, and protein levels were
determined by the method of Lowry et al. (35).
K+-stimulated uptake is defined as the difference between
uptake in 50 and 5 mM KCl buffers and represents 85 ± 1% (n = 10) of total uptake in 50 mM KCl
buffer.
(+)-[3H]PN200-110 Binding--
Binding of
(+)-[3H]PN200-110 to whole cells was measured as
described previously (36). Specific binding was determined by subtracting binding in the presence of 1 µM nimodipine
from binding in its absence and represents 51 ± 2%
(n = 10) of total binding at 50 pM
radioligand.
 |
RESULTS |
GF 109203X Prevents Ethanol-induced Increases in
K+-stimulated 45Ca2+
Uptake--
Previous work suggested that up-regulation of
L-type channels by ethanol requires activation of PKC since
it is prevented by the nonselective PKC inhibitors sphingosine and
polymyxin B (29). Since we had used a different clone of PC12 cells for these earlier studies, we needed to determine whether our current PC12
cell line responds similarly to ethanol. In control cells, 45Ca2+ uptake was 3.6 ± 0.21 nmol of
Ca2+/mg of protein/2.5 min (n = 103) and
was inhibited 92 ± 2% by the L-type channel antagonist
nimodipine (1 µM). Exposure to 25-150 mM
ethanol for 1-6 days increased K+-stimulated
45Ca2+ uptake assayed in the absence of ethanol
(Fig. 1 A and B).
This is similar to the increase we observed previously with another PC12 cell line (8), except that a maximal response was achieved at 6 days in those cells instead of at 5 days as observed in the current
cell line. To examine whether the increase in K+-stimulated
45Ca2+ uptake was PKC-dependent, we
cultured cells in the presence of 1 µM GF 109203X, which
is a relatively selective PKC inhibitor that inhibits all phorbol
ester-sensitive PKC isozymes except PKCµ (37, 38). As shown in Fig.
1A, GF 109203X prevented increases in
K+-stimulated 45Ca2+ uptake induced
by treatment with 150 mM ethanol for 6 days. Thus, ethanol
appears to increase K+-stimulated
45Ca2+ uptake in these cells by a
PKC-dependent mechanism.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Time course and concentration dependence of
increases in K+-stimulated 45Ca2+
uptake following exposure to ethanol. A,
45Ca2+ uptake was measured in PC12 cells
cultured with 150 mM ethanol ( ). Some cultures were
treated with 1 µM GF 109203X with ( ) or without ( )
ethanol. B, 45Ca2+ uptake was
measured in PC12 cells cultured for 6 days in the indicated
concentrations of ethanol. The data shown are the means ± S.E.
(n = 3-16) and are expressed as the percent above
45Ca2+ uptake measured in parallel control
cells cultured without ethanol.
|
|
Characterization of V1-expressing Cell Lines--
To investigate
whether PKC or PKC is required for up-regulation of
L-type calcium channels by ethanol, we created PC12 cell lines that stably express V1 fragments derived from the first variable
domains of PKC ( V1) and PKC ( V1). These fragments inhibit
phorbol ester-induced translocation and activation of their
corresponding PKC isozyme (32, 33). Characterization of
V1-expressing PC12 cell lines (V1 1 and V1 2) was described recently (33). Expression of the V1 fragment in V1 2, V1 3, and
V1 4 cells was confirmed by reverse transcriptase-polymerase chain
reaction (Fig. 2A) and Western
analysis (Fig. 2B). Treatment with 30 nM PMA
stimulated translocation of both PKC and PKC to the particulate
fraction in the parent PC12 cell line and in C cells transfected with
vector alone (Fig. 2, C and D). However, in cell
lines expressing the V1 fragment, translocation of PKC was
inhibited, whereas translocation of PKC was not (Fig. 2, C and D). In contrast, PMA-induced translocation
of PKC is selectively inhibited in V1-expressing lines (33).
Thus, expression of V1 or V1 fragments selectively inhibits
phorbol ester-stimulated translocation of the corresponding PKC isozyme
in these cells.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
Characterization of stably transfected PC12
cells expressing Flag epitope-tagged V1. A, reverse
transcriptase-polymerase chain reaction products were analyzed on 1.2%
agarose gels to demonstrate expression of V1-Flag mRNA in clones
V1 2, V1 3, and V1 4. No product was found in PC12 cells or C
cells transfected with vector alone. kb, kilobase;
Std, DNA size markers. B, lysates of V1 2,
V1 3, and V1 4 cells were analyzed on Western blots to detect the
presence of 17-kDa Flag immunoreactivity that comigrates with purified
Flag-tagged V1 expressed in bacteria ( -Flag).
C, cells were treated with 30 nM PMA for 2 min
to induce PKC translocation and then fractionated into cytosolic
(Cy) and particulate (P) cell fractions. PKC
and PKC immunoreactivity in cell fractions was detected by Western
analysis. The data shown are from a representative experiment.
D, PKC isozyme-specific immunoreactivity on Western blots of
cytosolic and particulate fractions was quantified by scanning
densitometry and is expressed as a percentage of total
immunoreactivity. PKC isozyme translocation was then calculated as the
increase in isozyme-specific immunoreactivity found in the particulate
fraction following treatment with PMA. The data shown are the
means ± S.E. from four to seven experiments. *, p < 0.01 compared with PC12 or C cells (ANOVA and Newman-Keuls
test).
|
|
The V1 Fragment Prevents Ethanol-induced Increases in
K+-stimulated 45Ca2+
Uptake--
To determine whether PKC or PKC mediates
ethanol-induced increases in L-type channel function, we
measured K+-stimulated 45Ca2+
uptake in cells expressing V1 or V1. Expressed as a percentage of
K+-stimulated 45Ca2+ uptake
measured in PC12 cells, uptake was similar (p = 0.11; ANOVA) in C (88 ± 6%, n = 23), V1 2 (107 ± 10%, n = 15), V1 3 (118 ± 7%,
n = 6), V1 4 (85 ± 6%, n = 8),
V1 1 (101 ± 7%, n = 6), and V1 2 (98 ± 5%, n = 6) cells. Treatment with 150 mM
ethanol for 6 days increased 45Ca2+ uptake in
PC12, C, and V1-expressing cells to a similar extent (Fig.
3A). In contrast, ethanol was
much less effective in increasing 45Ca2+ uptake
in cells expressing the V1 fragment (Fig. 3A).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Ethanol-induced increases in
45Ca2+ uptake and dihydropyridine binding are
inhibited in cells expressing V1. Cells were treated with 150 mM ethanol for 6 days. A, depolarization-induced
45Ca2+ uptake was measured in PC12 cells,
vector-transfected cells (C), and cells expressing the V1
fragment (V1 2, V1 3, or V1 4) or the V1 fragment (V1 1 or
V1 2). The data shown are the means ± S.E. (n = 5-24) and are expressed as the percent above
45Ca2+ uptake measured in parallel control
cells cultured without ethanol. *, p < 0.05 compared
with PC12 or C cells (ANOVA and Newman-Keuls test). B,
binding of (+)-[3H]PN200-110 was measured in depolarized
cells, and the results are expressed as the percent above or below
specific binding measured in parallel control cells cultured without
ethanol. The data shown are the means ± S.E. (n = 6-9). *, p < 0.05 compared with PC12 or C cells
(ANOVA and Newman-Keuls test).
|
|
The V1 Fragment Prevents Ethanol-induced Increases in
Dihydropyridine Binding--
To determine if expression of the V1
fragment also prevents ethanol-induced increases in dihydropyridine
binding, we measured binding of the L-type calcium channel
antagonist (+)-[3H]PN200-110 to ethanol-treated cells
(36). For these studies, we selected the two V1-expressing clones in
which the response to ethanol was most inhibited in the
45Ca2+ uptake assay. Basal
(+)-[3H]PN200-110 binding to PC12 cells was 3.52 ± 0.43 fmol/mg (n = 15) and was similar
(p = 0.14; ANOVA) to binding measured in C (4.43 ± 0.42 fmol/mg, n = 7), V1 2 (3.78 ± 0.64 fmol/mg, n = 8), V1 3 (4.85 ± 0.49 fmol/mg,
n = 7), V1 1 (3.17 ± 0.32 fmol/mg, n = 8), and V1 2 (3.17 ± 0.37 fmol/mg,
n = 6) cells. Treatment with 150 mM ethanol
for 6 days increased binding to a similar extent in PC12, C, V1 1,
and V1 2 cells (Fig. 3B). In contrast, ethanol failed to
increase binding in V1 2 and V1 3 cells. These results suggest that
PKC is required for up-regulation of L-type channels by ethanol.
Overexpression of PKC --
To examine whether increases in
PKC are sufficient to increase L-channel density, we examined
(+)-[3H]PN200-110 binding in PC12 cell lines 1 and
2, which overexpress PKC (34). Compared with nontransfected PC12
cells, binding of 50 pM (+)-[3H]PN200-110 was
increased in 1 and 2 cells, but not in C cells transfected with
vector alone (Fig. 4). To determine
whether the increase in binding in PKC -overexpressing cells was due
to a change in binding affinity or binding site number, binding was measured in 2 cells at increasing concentrations of
(+)-[3H]PN200-110 (from 10 to 280 pM). Fig.
5 shows a representative experiment.
Scatchard analysis yielded similar values for the equilibrium
dissociation constant (KD) in PC12 (84 ± 4 pM) and 2 (102 ± 14 pM) cells
(p = 0.27; n = 3). In contrast, the
maximal number of binding sites (Bmax) in 2
cells (16.8 ± 1.9 fmol/mg) was greater (p < 0.028; n = 3) than the Bmax in
PC12 cells (10.0 ± 0.7 fmol/mg). These findings are consistent
with an increase in L-channel density rather than an increase in
binding affinity in cells that overexpress PKC . However, despite the increase in dihydropyridine binding, K+-stimulated
45Ca2+ uptake was not increased in 1 or 2
cells (Fig. 4).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
K+-stimulated
45Ca2+ uptake and dihydropyridine binding in
cells that overexpress PKC . K+-stimulated
45Ca2+ uptake (gray bars)
and binding of 50 pM (+)-[3H]PN200-110
(black bars) were measured in 1 and 2 cells
that overexpress rat PKC and in C cells transfected with vector
alone. The data shown are the means ± S.E. from 3 to 19 experiments and are expressed as the percent of uptake and binding
above or below that measured in parallel cultures of PC12 cells. *,
p < 0.016 by one-sample t test.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Saturation analysis of
(+)-[3H]PN200-110 specific binding in PC12 and 2
cells. Data from saturation isotherms (A) were
converted to Scatchard plots (B), and values for
KD ( 1/slope) and Bmax
(x intercept) were determined by linear regression analysis.
The data shown are from a representative experiment performed in
triplicate. Mean KD and Bmax ± S.E. from three experiments are given under "Results."
|
|
PKC -independent Regulation of L-type Channels by
Ethanol--
Since overexpression of PKC increased dihydropyridine
binding but not K+-stimulated
45Ca2+ uptake, we considered whether
enhancement of L-channel function by ethanol requires additional,
PKC -independent mechanisms. Initial evidence for a
PKC -independent mechanism was obtained by examining V1-expressing
cells treated with ethanol and PKC inhibitors. Although treatment with
GF 109203X substantially inhibited ethanol-induced increases in
K+-stimulated 45Ca2+ uptake in PC12
cells (Fig. 1A), in V1 4 cells, it did not prevent increases due to ethanol, which were 26 ± 3% of control in the absence and 25 ± 5% of control in the presence of GF 109203X
(p = 0.9; n = 6). This result indicates
that a PKC -independent mechanism activated by ethanol contributes to
L-channel up-regulation. To examine if such a PKC -independent
mechanism is required to increase L-channel function in
PKC -overexpressing cells, we treated 1 and 2 cells with 150 mM ethanol for 5 days. We predicted that this treatment
would markedly increase 45Ca2+ uptake with
little or no effect on dihydropyridine binding. Ethanol enhanced
K+-stimulated 45Ca2+ uptake in
these cells (Fig. 6A) without
increasing PKC immunoreactivity (Fig. 6B), consistent
with activation of a PKC -independent mechanism. However, the
increase in 45Ca2+ uptake was modest and
associated with a similar increase in dihydropyridine binding (Fig.
6A).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
Ethanol treatment of PKC -overexpressing
cells. Cells were treated with 150 mM ethanol for 5 days. A, K+-stimulated
45Ca2+ uptake (stippled
bars) and binding of 50 pM
(+)-[3H]PN200-110 (black bars) were
measured in PC12 cells and in 1 and 2 cells that overexpress
PKC . The data shown are the means ± S.E. from three to eight
uptake experiments and four binding experiments and are expressed as
the percent of uptake or binding above that measured in parallel
control cultures of each cell line treated without drugs.
Ethanol-induced increases in 45Ca2+ uptake and
dihydropyridine binding in 1 and 2 cells were significantly less
than in PC12 cells (p < 0.05; ANOVA and Newman-Keuls
test). B, shown is the PKC immunoreactivity on Western
blots of total cell lysates (mean ± S.E., n = 2).
Inset, Western blot of control (C) and
ethanol-treated (E) cells from a representative experiment.
The data shown are expressed as the percent of PKC immunoreactivity
above or below that measured in parallel control cultures of each cell
line treated without ethanol.
|
|
 |
DISCUSSION |
In this paper, we found that ethanol-induced increases in
L-channel density and function were largely prevented by expression of
V1, a selective inhibitor of PKC translocation. In contrast, expression of V1, which inhibits PKC translocation, did not prevent L-channel up-regulation. Expression of V1 did not alter L-channel density or function in the absence of ethanol. These results
indicate that PKC , but not PKC , is important for ethanol-induced increases in functional L-type calcium channels in PC12
cells, but not for the basal activity of these channels.
Since ethanol increases the abundance of PKC (30), we examined
whether overexpression of PKC would mimic the effect of ethanol on
L-channel density and function. Although PKC overexpression increased the number of dihydropyridine-binding sites in PC12 cells, it
did not increase K+-stimulated
45Ca2+ uptake. This could have occurred because
PKC -independent mechanisms are also required to increase channel
function. Two results provided evidence for PKC -independent
mechanisms that are activated by ethanol. In V1 4 cells, PKC
translocation was completely blocked with only partial suppression of
the response to ethanol, and the remaining ethanol-induced response was
resistant to the PKC inhibitor GF 109203X. Moreover, in
PKC -overexpressing cells, ethanol increased
K+-stimulated 45Ca2+ uptake and
dihydropyridine binding without a further increase in PKC
immunoreactivity. These findings indicate that PKC -independent mechanisms contribute to up-regulation of L-type channels by
ethanol.
If PKC -independent mechanisms activated by ethanol are required for
increases in L-channel function, treatment of PKC -overexpressing cells with ethanol should have markedly increased
45Ca2+ uptake to levels commensurate with
levels of dihydropyridine binding in these cells. However, this did not
occur. PKC overexpression alone increased dihydropyridine binding by
~1.6-fold (Fig. 4), and ethanol treatment by another 1.4-fold (Fig.
6), for a combined increase of 2.2-fold over binding in untreated PC12
cells. In contrast, PKC overexpression and ethanol treatment
together only increased 45Ca2+ uptake by
1.4-fold over uptake in untreated PC12 cells (Figs. 4 and 6). It
appears that inactivity of PKC -independent mechanisms cannot explain
why PKC overexpression alone increased L-channel density, but not
L-channel function.
It is possible that increases in channel density evoked by stable
overexpression of PKC activate homeostatic mechanisms that reduce
channel function to maintain a set level of calcium signaling. These
mechanisms could act by decreasing L-channel function through altered
subunit composition or phosphorylation or by increasing calcium efflux
through increased Na+-Ca2+ exchange and the
action of membrane ATPases (39). Homeostatic mechanisms that regulate
channel density are activated by treatments that alter L-channel
activity. For example, prolonged treatment with drugs such as ethanol
(8, 9, 14-16), morphine (40), or nifedipine (41), which inhibit
L-channel activity, increases L-channel density. In contrast, prolonged
activation by exposure to depolarizing concentrations of KCl (42) or
the L-channel agonist Bay K8644 (43) decreases L-channel density. It
appears that L-channel function is highly regulated, and any alteration in channel activity or density leads to compensatory responses that
serve to normalize function in the continued presence of the perturbing
stimulus. Further studies will be needed to identify these compensatory
mechanisms and to determine if they are activated in
PKC -overexpressing cells.
One mechanism by which ethanol, acting via PKC , could increase
L-channel density is by increasing expression of channel subunits. Neuronal high voltage-activated calcium channels are multimeric complexes of at least three types of subunits: 1,
2 , and (44). The major pharmacological and
physiological features that distinguish different classes of
voltage-gated channels are mainly due to 1 subunits,
which contain the calcium pore and binding sites for selective calcium
channel antagonists. There are five genes known to encode
1 subunits in brain ( 1A,
1B, 1C, 1D, and
1E), and 1C and 1D are
subunits of L-type channels (45-48). PC12 cells express
1C (49). Transfected 1C can form
functional L-type channels, and coexpression with 2
or subunits results in increased channel function and a
corresponding increase in dihydropyridine binding (47, 50-54). Thus,
ethanol-induced increases in abundance of 1C,
2 , or subunits could increase the number of
functional L-type channels. This might occur at a transcriptional level
since PKC activates AP-1/Jun-regulated gene expression (55, 56).
Studies are currently underway to determine if chronic exposure to
ethanol regulates expression of specific calcium channel subunits by a
PKC -dependent mechanism.
PKC is ubiquitously expressed and has been implicated in control of
cell growth (56-58), apoptosis (59), and exocytosis (60) in
non-neuronal cells. Little is known about its role in neuronal cells.
It is induced in rat brain through an
N-methyl-D-aspartate receptor-dependent mechanism after transient focal ischemia
(61), but its role in brain injury or repair is not known. PKC binds to the growth-associated protein GAP-43 and appears to act as a GAP-43
kinase (62). However, it is not yet clear if PKC specifically regulates functions such as neurite growth or neurotransmitter release,
which appear to be modulated by GAP-43 (63, 64). Our results provide
the first evidence of a functional role for PKC in neural cells. Our
findings identify PKC as a regulator of L-channel density and a
mediator of cellular adaptation to ethanol. Since L-type channels
modulate drinking behavior (17-20) and contribute to manifestations of
alcohol withdrawal (22-24), PKC may play a key role in alcohol
consumption and dependence. Ongoing studies will determine if
inhibition of PKC reduces ethanol consumption and the development of
alcohol dependence in animals.
 |
FOOTNOTES |
*
This work was supported by grants from the National
Institute on Alcohol Abuse and Alcoholism and from the Alcoholic
Beverage Medical Research Foundation (to R. O. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
To whom correspondence and reprint requests should be
addressed: Bldg. 1, Rm. 101, 1001 Potrero Ave., San Francisco, CA
94110. Tel.: 415-648-7111; Fax: 415-648-7116; E-mail:
romes{at}itsa.ucsf.edu.
1
The abbreviations used are: PKC, protein kinase
C; PMA, phorbol 12-myristate 13-acetate; ANOVA, analysis of
variance.
 |
REFERENCES |
-
Goldstein, D. B.
(1983)
Pharmacology of Alcohol, Oxford University Press, New York
-
Miyakawa, T.,
Yagi, T.,
Kitazawa, H.,
Yasuda, M.,
Kawai, N.,
Tsuboi, K.,
and Niki, H.
(1997)
Science
278,
698-701[Abstract/Free Full Text]
-
Urso, T.,
Gavaler, J. S.,
and Van Thiel, D. H.
(1981)
Life Sci.
28,
1053-1056[CrossRef][Medline]
[Order article via Infotrieve]
-
Lindblad, B.,
and Olsson, R.
(1976)
J. Am. Med. Assoc.
236,
1600-1602[Abstract/Free Full Text]
-
Oakes, S. G.,
and Pozos, R. S.
(1982)
Dev. Brain Res.
5,
251-255
-
Harris, R. A.,
and Hood, W. F.
(1980)
J. Pharmacol. Exp. Ther.
213,
562-568[Abstract/Free Full Text]
-
Leslie, S. W.,
Barr, E.,
Chandler, J.,
and Farrar, R. P.
(1983)
J. Pharmacol. Exp. Ther.
225,
571-575[Abstract/Free Full Text]
-
Messing, R. O.,
Carpenter, C. L.,
and Greenberg, D. A.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
6213-6215[Abstract/Free Full Text]
-
Skattebol, A.,
and Rabin, R.
(1987)
Biochem. Pharmacol.
36,
2227-2229[CrossRef][Medline]
[Order article via Infotrieve]
-
Twombly, D. A.,
Herman, M. D.,
Kye, C. H.,
and Narahashi, T.
(1990)
J. Pharmacol. Exp. Ther.
254,
1029-1037[Abstract/Free Full Text]
-
Mullikin-Kilpatrick, D.,
and Treistman, S. N.
(1995)
J. Pharmacol. Exp. Ther.
272,
489-497[Abstract/Free Full Text]
-
Mullikin-Kilpatrick, D.,
Mehta, N. D.,
Hildebrandt, J. D.,
and Treistman, S. N.
(1995)
Mol. Pharmacol.
47,
997-1005[Abstract]
-
Wang, X.,
Wang, G.,
Lemos, J. R.,
and Treistman, S. N.
(1994)
J. Neurosci.
14,
5453-5460[Abstract]
-
Grant, A. J.,
Koski, G.,
and Treistman, S. N.
(1993)
Brain Res.
600,
280-284[CrossRef][Medline]
[Order article via Infotrieve]
-
Bergamaschi, S.,
Battaini, F.,
Trabucchi, M.,
Parenti, M.,
Lopez, C. M.,
and Govoni, S.
(1995)
Alcohol
12,
497-503[CrossRef][Medline]
[Order article via Infotrieve]
-
Dolin, S.,
Little, H.,
Hudspith, M.,
Pagonis, C.,
and Littleton, J.
(1987)
Neuropharmacology
26,
275-279[CrossRef][Medline]
[Order article via Infotrieve]
-
Fadda, F.,
Garau, B.,
Colombo, G.,
and Gessa, G. L.
(1992)
Alcohol Clin. Exp. Res.
16,
449-452[CrossRef][Medline]
[Order article via Infotrieve]
-
Colombo, G.,
Agabio, R.,
Lobina, C.,
Reali, R.,
Fadda, F.,
and Gessa, G. L.
(1994)
Eur. J. Pharmacol.
265,
167-170[CrossRef][Medline]
[Order article via Infotrieve]
-
Rezvani, A. H.,
and Janowsky, D. S.
(1990)
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
14,
623-631[CrossRef][Medline]
[Order article via Infotrieve]
-
Rezvani, A. H.,
Grady, D. R.,
and Janowsky, D. S.
(1991)
Alcohol Alcohol.
26,
161-167[Abstract/Free Full Text]
-
Victor, M.,
and Adams, R. D.
(1953)
Res. Publ. Assoc. Res. Nerv. Ment. Dis.
32,
526-573[Medline]
[Order article via Infotrieve]
-
Bone, G. H.,
Majchrowicz, E.,
Martin, P. R.,
Linnoila, M.,
and Nutt, D. J.
(1989)
Psychopharmacology
99,
386-388[CrossRef][Medline]
[Order article via Infotrieve]
-
Little, H. J.,
Dolin, S. J.,
and Halsey, M. J.
(1986)
Life Sci.
39,
2059-2065[CrossRef][Medline]
[Order article via Infotrieve]
-
Littleton, J. M.,
Little, H. J.,
and Whittington, M. A.
(1990)
Psychopharmacology
100,
387-392[CrossRef][Medline]
[Order article via Infotrieve]
-
Brennan, C. H.,
Crabbe, J.,
and Littleton, J. M.
(1990)
Neuropharmacology
29,
429-432[CrossRef][Medline]
[Order article via Infotrieve]
-
Nishizuka, Y.
(1992)
Science
258,
607-614[Abstract/Free Full Text]
-
Selbie, L. A.,
Schmitz-Peiffer, C.,
Sheng, Y.,
and Biden, T. J.
(1993)
J. Biol. Chem.
268,
24296-24302[Abstract/Free Full Text]
-
Johannes, F.-J.,
Prestle, J.,
Eis, S.,
Oberhagemann, P.,
and Pfizenmaier, K.
(1994)
J. Biol. Chem.
269,
6140-6148[Abstract/Free Full Text]
-
Messing, R. O.,
Sneade, A. B.,
and Savidge, B.
(1990)
J. Neurochem.
55,
1383-1389[Medline]
[Order article via Infotrieve]
-
Messing, R. O.,
Petersen, P. J.,
and Henrich, C. J.
(1991)
J. Biol. Chem.
266,
23428-23432[Abstract/Free Full Text]
-
Roivainen, R.,
Hundle, B.,
and Messing, R. O.
(1994)
in
Toward a Molecular Basis of Alcohol Use and Abuse (Jansson, B., Jörvall, H., Rydberg, U., Terenius, L., and Vallee, B. L., eds), pp. 29-38, Birkhäuser Verlag, Basel, Switzerland
-
Johnson, J. A.,
Gray, M. O.,
Chen, C.-H.,
and Mochly-Rosen, D.
(1996)
J. Biol. Chem.
271,
24962-24966[Abstract/Free Full Text]
-
Hundle, B.,
McMahon, T.,
Dadgar, J.,
Chen, C.-H.,
Mochly-Rosen, D.,
and Messing, R. O.
(1997)
J. Biol. Chem.
272,
15028-15035[Abstract/Free Full Text]
-
Hundle, B.,
McMahon, T.,
Dadgar, J.,
and Messing, R. O.
(1995)
J. Biol. Chem.
270,
30134-30140[Abstract/Free Full Text]
-
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275[Free Full Text]
-
Greenberg, D. A.,
Carpenter, C. L.,
and Messing, R. O.
(1986)
J. Pharmacol. Exp. Ther.
238,
1021-1027[Abstract/Free Full Text]
-
Gschwendt, M.,
Dieterich, S.,
Rennecke, J.,
Kittstein, W.,
Mueller, H.-J.,
and Johannes, F.-J.
(1996)
FEBS Lett.
392,
77-80[CrossRef][Medline]
[Order article via Infotrieve]
-
Toullec, D.,
Pianetti, P.,
Coste, H.,
Bellevergue, P.,
Grand-Perret, T.,
Ajakane, M.,
Baudet, V.,
Boissin, P.,
Boursier, E.,
Loriolle, F.,
Duhamel, L.,
Charon, D.,
and Kirilovsky, J.
(1991)
J. Biol. Chem.
266,
15771-15781[Abstract/Free Full Text]
-
Clapham, D. E.
(1995)
Cell
80,
259-268[CrossRef][Medline]
[Order article via Infotrieve]
-
Ramkumar, V.,
and El-Fakahany, E. E.
(1988)
Eur. J. Pharmacol.
146,
73-83[CrossRef][Medline]
[Order article via Infotrieve]
-
Panza, G.,
Grebb, J. A.,
Sanna, E.,
Wright, A. G., Jr.,
and Hanbauer, I.
(1985)
Neuropharmacology
24,
1113-1117[CrossRef][Medline]
[Order article via Infotrieve]
-
Delorme, E. M.,
and McGee, R., Jr.
(1986)
Brain Res.
397,
189-192[CrossRef][Medline]
[Order article via Infotrieve]
-
Nikodijevic, B.,
Nikodijevic-Kedeva, D.,
Oshima, M.,
Paige, B.,
and Guroff, G.
(1994)
J. Neurosci. Res.
37,
71-82[CrossRef][Medline]
[Order article via Infotrieve]
-
McClesky, E. W.
(1994)
Curr. Opin. Neurobiol.
4,
304-312[CrossRef][Medline]
[Order article via Infotrieve]
-
Hui, A.,
Ellinor, P. T.,
Krizanova, O.,
Wang, J.-J.,
Diebold, R. J.,
and Schwartz, A.
(1991)
Neuron
7,
35-44[CrossRef][Medline]
[Order article via Infotrieve]
-
Snutch, T. P.,
Tomlinson, W. J.,
Leonard, J. P.,
and M., G. M.
(1991)
Neuron
7,
45-57[CrossRef][Medline]
[Order article via Infotrieve]
-
Williams, M. E.,
Feldman, D. H.,
McCue, A. F.,
Brenner, R.,
Velicelebi, G.,
Ellis, S. B.,
and Harpold, M. M.
(1992)
Neuron
8,
71-84[CrossRef][Medline]
[Order article via Infotrieve]
-
Hell, J. W.,
Westenbroek, R. E.,
Warner, C.,
Ahijanian, M. K.,
Prystay, W.,
Gilbert, M. M.,
Snutch, T. P.,
and Catterall, W. A.
(1993)
J. Cell Biol.
123,
949-962[Abstract/Free Full Text]
-
Liu, H.,
Felix, R.,
Gurnett, C. A.,
De Waard, M.,
Witcher, D. R.,
and Campbell, K. P.
(1996)
J. Neurosci.
16,
7557-7565[Abstract/Free Full Text]
-
Shistik, E.,
Ivanina, T.,
Puri, T.,
Hosey, M.,
and Dascal, N.
(1995)
J. Physiol. (Lond.)
489,
55-62[Abstract/Free Full Text]
-
Hullin, R.,
Singer-Lahat, D.,
Freichel, M.,
Biel, M.,
Dascal, N.,
Hofmann, F.,
and Flockerzi, V.
(1992)
EMBO J.
11,
885-890[Medline]
[Order article via Infotrieve]
-
Massa, E.,
Kelly, K. M.,
Yule, D. I.,
Macdonald, R. L.,
and Uhler, M. D.
(1995)
Mol. Pharmacol.
47,
707-716[Abstract]
-
Perez-Garcia, M. T.,
Kamp, T. J.,
and Marban, E.
(1995)
J. Gen. Physiol.
105,
289-306[Abstract/Free Full Text]
-
Nishimura, S.,
Hiroshi, T.,
Hofmann, F.,
Flockerzi, V.,
and Imoto, K.
(1993)
FEBS Lett.
324,
283-286[CrossRef][Medline]
[Order article via Infotrieve]
-
Hirai, S.,
Izumi, Y.,
Higa, K.,
Kaibuchi, K.,
Mizuno, K.,
Osada, S.,
Suzuki, K.,
and Ohno, S.
(1994)
EMBO J.
13,
2331-2340[Medline]
[Order article via Infotrieve]
-
Li, W.,
Michieli, P.,
Alimandi, M.,
Lorenzi, M. V.,
Wu, Y.,
Wang, L.-H.,
Heidaran, M. A.,
and Pierce, J. H.
(1996)
Oncogene
13,
731-737[Medline]
[Order article via Infotrieve]
-
Mischak, H.,
Pierce, J. H.,
Goodnight, J.,
Kazanietz, M. G.,
Blumberg, P. M.,
and Mushinski, J. F.
(1993)
J. Biol. Chem.
268,
20110-20115[Abstract/Free Full Text]
-
Fukumoto, S.,
Nishizawa, Y.,
Hosoi, M.,
Koyama, H.,
Yamakawa, K.,
Ohno, S.,
and Morii, H.
(1997)
J. Biol. Chem.
272,
13816-13822[Abstract/Free Full Text]
-
Ghayur, T.,
Hugunin, M.,
Talanian, R. V.,
Ratnofsky, S.,
Quinlan, C.,
Emoto, Y.,
Pandey, P.,
Datta, R.,
Huang, Y. Y.,
Kharbanda, S.,
Allen, H.,
Kamen, R.,
Wong, W.,
and Kufe, D.
(1996)
J. Exp. Med.
184,
2399-2404[Abstract/Free Full Text]
-
Ozawa, K.,
Szallasi, Z.,
Kazanietz, M. G.,
Blumberg, P. M.,
Mischak, H.,
Mushinski, J. F.,
and Beaven, M. A.
(1993)
J. Biol. Chem.
268,
1749-1756[Abstract/Free Full Text]
-
Miettinen, S.,
Roivainen, R.,
Keinänen, R.,
Hökfelt, T.,
and Koistinaho, J.
(1996)
J. Neurosci.
16,
6236-6245[Abstract/Free Full Text]
-
Dekker, L. V.,
and Peter, P. J.
(1997)
J. Biol. Chem.
272,
12747-12753[Abstract/Free Full Text]
-
Aigner, L.,
and Caroni, P.
(1993)
J. Cell Biol.
123,
417-429[Abstract/Free Full Text]
-
Ivins, K. J.,
Neve, K. A.,
Feller, D. J.,
Fidel, S. A.,
and Neve, R. L.
(1993)
J. Neurochem.
60,
626-633[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. N. Churchill, M.-H. Disatnik, G. R. Budas, and D. Mochly-Rosen
Ethanol for cardiac ischemia: the role of protein kinase c
Therapeutic Advances in Cardiovascular Disease,
December 1, 2008;
2(6):
469 - 483.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Maddali, D. H. Korzick, D. L. Tharp, and D. K. Bowles
PKC{delta} Mediates Testosterone-induced Increases in Coronary Smooth Muscle Cav1.2
J. Biol. Chem.,
December 30, 2005;
280(52):
43024 - 43029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Jung, M. B. Gatch, and J. W. Simpkins
Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms
Experimental Biology and Medicine,
January 1, 2005;
230(1):
8 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Hendricson, M. P. Thomas, M. J. Lippmann, and R. A. Morrisett
Suppression of L-Type Voltage-Gated Calcium Channel-Dependent Synaptic Plasticity by Ethanol: Analysis of Miniature Synaptic Currents and Dendritic Calcium Transients
J. Pharmacol. Exp. Ther.,
November 1, 2003;
307(2):
550 - 558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Tapia, L. J. Garcia-Marin, and R. T. Jensen
Cholecystokinin-stimulated Protein Kinase C-{delta} Kinase Activation, Tyrosine Phosphorylation, and Translocation Are Mediated by Src Tyrosine Kinases in Pancreatic Acinar Cells
J. Biol. Chem.,
September 12, 2003;
278(37):
35220 - 35230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Nelson, K. Hellevuo, M. Yoshimura, and B. Tabakoff
Ethanol-induced Phosphorylation and Potentiation of the Activity of Type 7 Adenylyl Cyclase. INVOLVEMENT OF PROTEIN KINASE C delta
J. Biol. Chem.,
February 7, 2003;
278(7):
4552 - 4560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Torocsik, J. M. Angelastro, and L. A. Greene
The Basic Region and Leucine Zipper Transcription Factor MafK Is a New Nerve Growth Factor-Responsive Immediate Early Gene That Regulates Neurite Outgrowth
J. Neurosci.,
October 15, 2002;
22(20):
8971 - 8980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Knott, A. M. Dopico, G. Dayanithi, J. Lemos, and S. N. Treistman
Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals
Mol. Pharmacol.,
July 1, 2002;
62(1):
135 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Katsura, Y. Mohri, K. Shuto, Y. Hai-Du, T. Amano, A. Tsujimura, M. Sasa, and S. Ohkuma
Up-regulation of L-type Voltage-dependent Calcium Channels after Long Term Exposure to Nicotine in Cerebral Cortical Neurons
J. Biol. Chem.,
March 1, 2002;
277(10):
7979 - 7988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Benes and S. P. Soltoff
Modulation of PKC{delta} tyrosine phosphorylation and activity in salivary and PC-12 cells by Src kinases
Am J Physiol Cell Physiol,
June 1, 2001;
280(6):
C1498 - C1510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A. Dina, J. Barletta, X. Chen, A. Mutero, A. Martin, R. O. Messing, and J. D. Levine
Key Role for the Epsilon Isoform of Protein Kinase C in Painful Alcoholic Neuropathy in the Rat
J. Neurosci.,
November 15, 2000;
20(22):
8614 - 8619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. RON, A. J. VAGTS, D. P. DOHRMAN, R. YAKA, Z. JIANG, L. YAO, J. CRABBE, J. E. GRISEL, and I. DIAMOND
Uncoupling of {beta}IIPKC from its targeting protein RACK1 in response to ethanol in cultured cells and mouse brain
FASEB J,
November 1, 2000;
14(14):
2303 - 2314.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Guo, W. R. Giles, and C. A. Ward
Effect of hydrogen peroxide on the membrane currents of sinoatrial node cells from rabbit heart
Am J Physiol Heart Circ Physiol,
September 1, 2000;
279(3):
H992 - H999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. McMahon, R. Andersen, P. Metten, J. C. Crabbe, and R. O. Messing
Protein Kinase C epsilon Mediates Up-Regulation of N-Type Calcium Channels by Ethanol
Mol. Pharmacol.,
January 1, 2000;
57(1):
53 - 58.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N.-K. Huang, Y.-W. Lin, C.-L. Huang, R. O. Messing, and Y. Chern
Activation of Protein Kinase A and Atypical Protein Kinase C by A2A Adenosine Receptors Antagonizes Apoptosis Due to Serum Deprivation in PC12 Cells
J. Biol. Chem.,
April 20, 2001;
276(17):
13838 - 13846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Walter, T. McMahon, J. Dadgar, D. Wang, and R. O. Messing
Ethanol Regulates Calcium Channel Subunits by Protein Kinase C delta -dependent and -independent Mechanisms
J. Biol. Chem.,
August 11, 2000;
275(33):
25717 - 25722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao, W. Tian, and D. M. Cohen
Rottlerin inhibits tonicity-dependent expression and action of TonEBP in a PKCdelta -independent fashion
Am J Physiol Renal Physiol,
April 1, 2002;
282(4):
F710 - F717.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|